#1 Clinical Trials Search in Europe

Sulodexide

Sulodexide is a medication being studied in clinical trials for its potential benefits in treating various vascular and kidney-related conditions. This article summarizes key findings from recent clinical trials investigating sulodexide for conditions like endothelial dysfunction, diabetic nephropathy, and venous thromboembolism. We’ll explore how sulodexide may help protect blood vessels, reduce inflammation, and improve outcomes for patients with these health issues.

Table of Contents

What is Sulodexide?

Sulodexide is a medication that belongs to a class of drugs called glycosaminoglycans (GAGs). It is derived from natural sources, specifically porcine intestinal mucosa[1]. Sulodexide is known by several other names, including:

This medication is unique because it can be taken orally and does not have the strong blood-thinning effects associated with similar drugs when taken by mouth[1].

What Conditions Does Sulodexide Treat?

Sulodexide is being studied and used to treat various conditions related to blood vessels and circulation. Some of the main conditions include:

  • Diabetic Nephropathy: A kidney disease that can occur in people with diabetes[1][2]
  • Diabetic Retinopathy: An eye condition that can affect people with diabetes, potentially leading to vision problems[5]
  • Venous Thromboembolism: A condition where blood clots form in the veins, usually in the legs[6]
  • Post-thrombotic Syndrome: A long-term condition that can occur after having a blood clot in a vein[4]
  • Chronic Venous Disease: A condition where veins have trouble sending blood from the legs back to the heart[4]
  • Endothelial Dysfunction: A type of non-obstructive coronary artery disease[3]
  • Tinnitus: A condition characterized by ringing or buzzing in the ears[7]

How Does Sulodexide Work?

Sulodexide works in several ways to improve vascular health:

  • Endothelial Protection: It helps protect and repair the inner lining of blood vessels (endothelium)[3]
  • Anti-thrombotic Effects: It helps prevent blood clots from forming[6]
  • Anti-inflammatory Properties: It can reduce inflammation in blood vessels[3]
  • Fibrinolytic Activity: It helps break down existing blood clots[4]

In conditions like diabetic nephropathy, Sulodexide may help by restoring the balance of certain molecules in the kidneys, potentially slowing down the progression of kidney damage[1].

How is Sulodexide Administered?

Sulodexide is typically taken orally in the form of capsules or gelcaps. The dosage and frequency can vary depending on the condition being treated and the specific study or treatment plan. Some common dosages mentioned in the trials include:

  • 250 LSU (Lipasemic Units) twice daily[3]
  • 100 mg twice daily[1]
  • 25 mg twice daily[7]

It’s important to note that the appropriate dosage should always be determined by a healthcare professional.

Potential Benefits of Sulodexide

Research suggests that Sulodexide may offer several benefits:

  • Reduced Protein in Urine: In diabetic nephropathy, it may help decrease the amount of protein (albumin) in the urine, which is a sign of kidney damage[1]
  • Improved Eye Health: In diabetic retinopathy, it may help reduce damage to the blood vessels in the eyes[5]
  • Prevention of Blood Clots: It may help prevent recurrent venous thromboembolism, especially in older patients[6]
  • Better Quality of Life: In post-thrombotic syndrome, it may improve symptoms and quality of life when used alongside compression therapy[4]
  • Potential Tinnitus Relief: Some research is exploring its effects on tinnitus symptoms[7]

Ongoing Research and Future Potential

Sulodexide is still being actively studied for various conditions. Some areas of ongoing research include:

  • Post-COVID-19 Treatment: Investigating its potential to protect blood vessels in patients recovering from COVID-19[3]
  • Varicose Veins: Studying its effects on reducing complications after certain treatments for varicose veins[8]
  • Rare Kidney Diseases: Exploring its potential in conditions like Dense Deposit Disease[9]

Possible Side Effects

While Sulodexide is generally considered to have a good safety profile, it’s important to be aware of potential side effects. The most commonly reported side effect is an increased risk of bleeding, although this risk is generally lower than with other similar medications[6]. Always discuss potential risks and side effects with your healthcare provider before starting any new medication.

Condition Study Design Dosage Duration Key Findings
Post-COVID-19 Endothelial Dysfunction Randomized, placebo-controlled 250 LSU twice daily 8 weeks May improve endothelial function biomarkers
Diabetic Nephropathy Randomized, placebo-controlled 200-400 mg daily 6-12 months Potential reduction in urinary albumin excretion
Venous Thromboembolism Prevention Randomized, placebo-controlled 250-500 mg twice daily 12 months May reduce VTE recurrence in elderly patients
Chronic Tinnitus Randomized, double-blind 25 mg twice daily 40 days Possible improvement in tinnitus symptoms
Varicose Veins Randomized, controlled 250 LSU twice daily 2 months May reduce adverse effects after treatment

FAQ

  • What is sulodexide and how does it work? Sulodexide is a medication made up of two types of molecules called glycosaminoglycans. It helps protect the lining of blood vessels, reduces inflammation, and may prevent blood clots. Sulodexide works by interacting with the walls of blood vessels to improve their function.
  • What conditions is sulodexide being studied for in clinical trials? Clinical trials are investigating sulodexide for several conditions, including endothelial dysfunction after COVID-19, diabetic nephropathy (kidney disease in diabetes), venous thromboembolism (blood clots), and chronic tinnitus. It's being studied to see if it can help protect blood vessels, reduce protein in urine, prevent blood clots, and improve symptoms.
  • How is sulodexide typically given in these trials? In most trials, sulodexide is given as oral capsules, usually taken twice daily. The dosage varies between studies, ranging from 250-500 LSU (Lipasemic Units) per day. Treatment duration in the trials ranges from 8 weeks to 12 months, depending on the condition being studied.
  • What are some potential benefits of sulodexide seen in trials so far? Early trial results suggest sulodexide may help improve endothelial function after COVID-19, reduce protein in urine for diabetic kidney disease, lower the risk of blood clot recurrence in elderly patients, and potentially improve symptoms of tinnitus. However, more research is needed to confirm these benefits.
  • Are there any side effects or safety concerns with sulodexide? Sulodexide appears to be generally well-tolerated in clinical trials. Some studies are specifically looking at bleeding risk, which is a potential concern with medications that affect blood clotting. However, sulodexide seems to have a low risk of major bleeding compared to other blood thinners. As with any medication, patients should discuss potential risks and benefits with their doctor.

Ongoing Clinical Trials on Sulodexide

  • Study on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Italy

Glossary

  • Endothelial dysfunction: A condition where the inner lining of blood vessels (endothelium) doesn't function properly, which can lead to various cardiovascular problems.
  • Diabetic nephropathy: Kidney damage that occurs in people with diabetes, often characterized by increased protein in the urine.
  • Venous thromboembolism (VTE): A condition where blood clots form in the veins, usually in the legs (deep vein thrombosis) or lungs (pulmonary embolism).
  • Microalbuminuria: A condition where small amounts of a protein called albumin are present in the urine, often an early sign of kidney damage in diabetes.
  • Glycosaminoglycans: Complex sugar molecules that play important roles in various biological processes, including blood vessel function.
  • Lipasemic Units (LSU): A measure of the activity of sulodexide used to determine dosage in clinical trials.
  • Tinnitus: A condition characterized by ringing or other noises in one or both ears that isn't caused by an external sound.
  • Placebo: An inactive substance given to some participants in a clinical trial to compare the effects of the real medication against no treatment.

References

  1. https://clinicaltrials.gov/study/NCT00130208
  2. https://clinicaltrials.gov/study/NCT00462202
  3. https://clinicaltrials.gov/study/NCT05371925
  4. https://clinicaltrials.gov/study/NCT02512601
  5. https://clinicaltrials.gov/study/NCT01295775
  6. https://clinicaltrials.eu/trial/study-on-sulodexide-for-preventing-recurrence-of-blood-clots-in-elderly-patients-after-first-episode-of-deep-vein-thrombosis-or-pulmonary-embolism/
  7. https://clinicaltrials.gov/study/NCT02737670
  8. https://clinicaltrials.gov/study/NCT05654233
  9. https://clinicaltrials.gov/study/NCT00583427